Literature DB >> 23633300

A newly recognized autosomal recessive syndrome affecting neurologic function and vision.

Mustafa A Salih1, Andreas Tzschach, Darren T Oystreck, Hamdy H Hassan, Abdulmajeed AlDrees, Salah A Elmalik, Heba Y El Khashab, Thomas F Wienker, Khaled K Abu-Amero, Thomas M Bosley.   

Abstract

Genetic factors represent an important etiologic group in the causation of intellectual disability. We describe a Saudi Arabian family with closley related parents in which four of six children were affected by a congenital cognitive disturbance. The four individuals (aged 18, 16, 13, and 2 years when last examined) had motor and cognitive delay with seizures in early childhood, and three of the four (sparing only the youngest child) had progressive, severe cognitive decline with spasticity. Two affected children had ocular malformations, and the three older children had progressive visual loss. The youngest had normal globes with good functional vision when last examined but exhibited the oculodigital sign, which may signify a subclinical visual deficit. A potentially deleterious nucleotide change (c.1A>G; p.Met1Val) in the C12orf57 gene was homozygous in all affected individuals, heterozygous in the parents, and absent in an unaffected sibling and >350 normal individuals. This gene has no known function. This family manifests a autosomal recessive syndrome with some phenotypic variability that includes abnormal development of brain and eyes, delayed cognitive and motor milestones, seizures, and a severe cognitive and visual decline that is associated with a homozygous variant in a newly identified gene.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23633300     DOI: 10.1002/ajmg.a.35850

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

1.  Temtamy syndrome caused by a new C12orf57 variant in a Chinese boy, including pedigree analysis and literature review.

Authors:  Yanqin Wang; Ming Li; Yuanyuan Luo; Xin Zhao; Shuang Liao; Li Jiang; Xiujuan Li; Min Zhong
Journal:  Exp Ther Med       Date:  2019-11-12       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.